In the realm of rare diseases, Sanofi has added another arrow to its Pompe quiver.
Sanofi has concluded an agreement to divest an integrated portfolio of dental care brands and related medical devices to Septodont, a French privately-owned company headquartered near Paris.
Sanofi has got a tropical disease priority review voucher from the FDA approval of the first all-oral regimen for sleeping sickness.
As a national sponsor for the Paris Olympic Games in 2024, Sanofi expects to reinforce its social and environmental commitments.
Sanofi announces Paris 2024 Premium partnership for the Olympic